drugset
drugset / Trial / NCT01891019

Thalidomide in the Treatment of Chronic Plaque Psoriasis.

NCT01891019 ↗

Phase 2 Completed 21 enrolled Wake Forest University
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to obtain information on the effectiveness of thalidomide in psoriasis.

Timeline

Start
2003-04
Primary completion
2005-09
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Thalidomide Other / unclassified 200 mg Oral

Indications

psoriasis